Patents Assigned to Glenmark Generics Ltd.
  • Patent number: 8937188
    Abstract: A solid crystalline form of 1-(2-[4-(6-methoxy-3,4-dihydronaphthalene-1-y) phenoxy]ethyl)pyrrolidine, and a preparing process thereof are provided. The aforesaid compound is a key intermediate in the synthesis of lasofoxifene. A process for preparing lasofoxifene, a process for purifying lasofoxifene tartrate, and a crystalline form of lasofoxifene tartrate are also provided.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: January 20, 2015
    Assignee: Glenmark Generics Ltd.
    Inventors: Mubeen Ahmed Khan, Nikhil Rasiklal Trivedi, Nagan Nirmalan Kandasamy, Dayaghan Gangadhar Patil, Vipin Kumar Pandey, Sukumar Sinha
  • Publication number: 20140072628
    Abstract: Disclosed herein is a stable pharmaceutical composition comprising a substrate having deposited on its surface a layer comprising saxagliptin or pharmaceutically acceptable salts thereof, wherein a seal coat is not present between the substrate and the saxagliptin layer.
    Type: Application
    Filed: September 11, 2013
    Publication date: March 13, 2014
    Applicant: Glenmark Generics Ltd.
    Inventors: Atul Kaushik, Arra Ganga Srinivas, Kamal Mehta
  • Patent number: 8624041
    Abstract: A process for the preparation of strontium ranelate or a hydrate thereof is provided comprising (a) reacting a tetraester compound of Formula II: wherein R, R1, R2, and R3 are independently a linear or branched C1-C6 alkyl group or a substituted or unsubstituted C3-C12 cyclic group, in the presence of a lithium base and in a solvent with an inorganic acid salt of strontium.
    Type: Grant
    Filed: August 18, 2006
    Date of Patent: January 7, 2014
    Assignee: Glenmark Generics Ltd.
    Inventors: Bobba Venkata Siva Kumar, Kosampally Srinivas, Sanjay Anantha Kale, Nitin Sharad Chandra Pradhan
  • Patent number: 8450376
    Abstract: The present invention provides an amorphous bupropion hydrobromide and an amorphous bupropion hydrobromide granulates with at least one pharmaceutically acceptable carrier, and a process for its preparation.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: May 28, 2013
    Assignee: Glenmark Generics Ltd.
    Inventors: Shankar Sanganabhatla, Vijay Soni, Mubeen Ahmed Khan, Nandlal Agarwal, Hemanth Kamble, Sharad Gore
  • Publication number: 20120028045
    Abstract: The present invention relates to processes for the preparation of indiplon and its polymorphic mixtures.
    Type: Application
    Filed: March 18, 2010
    Publication date: February 2, 2012
    Applicant: Glenmark Generics LTD
    Inventors: Joseph Prabahar Koilpillai, Sanjay Anantha Kale, Laxmikant Madhukar Kelkar, Sunil Sudhakar Zope, Mubeen Ahmed Khan
  • Publication number: 20120022047
    Abstract: The present invention relates to the purification and particle size of eslicarbazepine acetate. The present invention also relates to the physical characteristics of solid state eslicarbazepine acetate, and pharmaceutical compositions containing the same.
    Type: Application
    Filed: March 30, 2010
    Publication date: January 26, 2012
    Applicant: GLENMARK GENERICS LTD
    Inventors: Joseph Prabahar Koilpillai, Pravin Bhalchandra Kulkarni, Sachin Bapurao Sawant, Nagesh Devidasrao Limbekar
  • Patent number: 8097729
    Abstract: Processes for the purification of lercanidipine hydrochloride are provided which uses a binary system of an alcohol-containing solvent such as methanol and an aliphatic ester-containing solvent such as isopropyl acetate. Processes for the preparation of substantially amorphous lercanidipine hydrochloride are also provided. Also provided is lercanidipine hydrochloride substantially in polymorph form V.
    Type: Grant
    Filed: September 18, 2006
    Date of Patent: January 17, 2012
    Assignee: Glenmark Generics Ltd.
    Inventors: Mangesh Shivram Sawant, Maloyesh Mathuresh Biswas, Mubeen Ahmed Khan, Sukumar Sinha, Nitin Sharad Chandra Pradhan
  • Publication number: 20110281928
    Abstract: The present invention relates to a process for the preparation of zofenopril and its pharmaceutically acceptable salts and a pharmaceutical composition thereof. The present invention also provides structurally novel compounds, which are useful intermediates in the synthesis of zofenopril.
    Type: Application
    Filed: January 24, 2010
    Publication date: November 17, 2011
    Applicant: GLENMARK GENERICS LTD
    Inventors: Mubeen Ahmed Khan, Roop Singh Yadav, Nikhil Rasiklal Trivedi, Sachin Mahedo Lad
  • Publication number: 20110207779
    Abstract: The present invention relates to a process for the preparation of esomeprazole magnesium containing R-isomer greater than about 0.1% by wt. In particular, the present invention relates to a process for the preparation of esomeprazole magnesium dihydrate containing R-isomer greater than about 0.1% by wt.
    Type: Application
    Filed: April 28, 2010
    Publication date: August 25, 2011
    Applicant: GLENMARK GENERICS LTD
    Inventors: Koilpillai Joseph Prabahar, Veerabhadra Swamy Hiremath, Milind Moreshwar Gharpure, Nagan Nirmalan Kandaswamy, Avekumar Digambar Dabe, Kamal Mehta, Pankajkumar Shinde
  • Publication number: 20110105619
    Abstract: The present invention provides an amorphous bupropion hydrobromide and an amorphous bupropion hydrobromide granulates with at least one pharmaceutically acceptable carrier, and a process for its preparation.
    Type: Application
    Filed: June 15, 2009
    Publication date: May 5, 2011
    Applicant: Glenmark Generics Ltd.
    Inventors: Shankar Sanganabhatla, Vijay Soni, Mubeen Ahmed Khan, Nandlal Agarwal, Hemanth Kamble, Sharad Gore
  • Publication number: 20110052687
    Abstract: The present invention provides an extended release tablet of paliperidone, comprising a) a core containing paliperidone and at least one water soluble and/or gellable polymer, b) a coating comprising at least one water insoluble or permeable polymer, and a water soluble and/or gellable polymer and optionally an enteric polymer.
    Type: Application
    Filed: August 25, 2010
    Publication date: March 3, 2011
    Applicant: GLENMARK GENERICS LTD
    Inventors: Kamal Mehta, Pankaj Shinde, Hidaytulla Aga, Rajadeep Gupta
  • Publication number: 20110053898
    Abstract: A topical pharmaceutical composition comprising therapeutically effective amounts of vitamin D or vitamin D analogues, corticosteroid and a straight chain C6-C28 fatty alcohol.
    Type: Application
    Filed: August 24, 2010
    Publication date: March 3, 2011
    Applicant: GLENMARK GENERICS LTD
    Inventors: Kamal Mehta, Amol Mandhare, Shantesh Patil, Tapan Nayak, Lalatendu Panigrahi
  • Publication number: 20110038928
    Abstract: The present invention is directed to a novel rapidly dissolvable pharmaceutical composition comprising zolmitriptan or pharmaceutically acceptable salts or esters thereof and least one direct compression filler. The pharmaceutical compositions of the present invention can advantageously be prepared in a solid dosage form, e.g. a tablet, utilizing directly compressible ingredients.
    Type: Application
    Filed: August 10, 2010
    Publication date: February 17, 2011
    Applicant: GLENMARK GENERICS LTD
    Inventors: Kamal Mehta, Srinivas Ganga Arra, Chandramala A. Kaushal, Manish Maheshwari
  • Patent number: 7863273
    Abstract: A substantially pure dextrorotatory isomer of zopiclone or a pharmaceutically acceptable salt thereof and crystalline forms thereof are provided. Also provided is a process for its preparation and pharmaceutical compositions containing same.
    Type: Grant
    Filed: December 29, 2006
    Date of Patent: January 4, 2011
    Assignee: Glenmark Generics Ltd.
    Inventors: Biju Kumar Gopinathen Pillai, Sankar Arjunan, Nitin Sharad Chandra Pradhan, Narendra Shriram Joshi
  • Publication number: 20100317856
    Abstract: The present invention provides processes for the preparation of R-sitagliptin and its pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: October 27, 2008
    Publication date: December 16, 2010
    Applicant: GLENMARK GENERICS LTD
    Inventor: SANKAR ARJUNAN
  • Publication number: 20100310870
    Abstract: The present invention relates to amorphous form of bazedoxifene acetate and a process for the preparation thereof.
    Type: Application
    Filed: March 16, 2010
    Publication date: December 9, 2010
    Applicant: GLENMARK GENERICS LTD.
    Inventors: Shankar Sanganabhatla, Sachin Srivastava, Dinesh Bansilal Deore, Anthony Melvin Crasto, Mubeen Ahmed Khan
  • Publication number: 20100292267
    Abstract: The present invention provides novel palonosetron free base in an amorphous form and crystalline form-G and processes for their preparation. The present invention also provides a process for the preparation of palonosetron hydrochloride from the novel palonosetron free base in an amorphous form and/or in crystalline form-G.
    Type: Application
    Filed: December 11, 2008
    Publication date: November 18, 2010
    Applicant: GLENMARK GENERICS LTD
    Inventors: Mubeen Khan, Mahendra Patil Raghunath, Prashant Yadav Kundlik
  • Publication number: 20100068284
    Abstract: The present invention relates to stable fixed dose topical formulations comprising an antiacne agent and an antibiotic, which exhibit storage stability at a temperature of about 40° C. and relative humidity of about 75% for a period of at least 3 months. Particularly, the present invention relates to stable fixed dose topical formulations comprising therapeutically effective amounts of (a) adapalene-containing microspheres and (b) clindamycin, a process for their preparation thereof and their use for the treatment of acne.
    Type: Application
    Filed: March 16, 2009
    Publication date: March 18, 2010
    Applicant: GLENMARK GENERICS LTD
    Inventors: Ulhas Rameshchandra Dhuppad, Nitin Babulal Bhamre, Sunil Sudhakar Chaudhari, Girish Trivedi, Akhilesh Dayanand Sharma, Prashant Dongre
  • Publication number: 20100028425
    Abstract: The present invention relates to immediate release pharmaceutical compositions for oral administration comprising micronized atovaquone particles and at least one drug, wherein about 90% of the atovaquone particles have a volume diameter between about 4 ?m to about 8 ?m; and having a uniform release profile after a storage for at least three months at 40° C. and 75% relative humidity.
    Type: Application
    Filed: July 22, 2009
    Publication date: February 4, 2010
    Applicant: GLENMARK GENERICS LTD.
    Inventors: Kamal Mehta, Sanjay Pandurang Lade, Srinivas G. Arra
  • Publication number: 20100008988
    Abstract: The present invention provides pharmaceutical compositions, essentially comprising less than about 95% by weight of an aliphatic amine polymer. The present invention relates to pharmaceutical compositions comprising aliphatic amine polymers of sevelamer hydrochloride, sevelamer carbonate and colesevelam hydrochloride; and methods of preparing pharmaceutical compositions thereof.
    Type: Application
    Filed: July 13, 2009
    Publication date: January 14, 2010
    Applicant: GLENMARK GENERICS, LTD.
    Inventors: KAMAL MEHTA, SRINIVAS GANGA ARRA, HIDAYTULLA AGA